TLR Agonist INI-4001 Improves Efficacy of Heroin Vaccine Intended for Clinical Treatment of Opioid Use Disorder is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5UG3DA047711-02
Phase 1a/1b Clinical Trials of Multivalent Opioid Vaccine Components
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
Keywords
Sustainable Development Goals